MET monthly performance report
Explore MET's monthly returns, drawdown, and seasonality trends — updated every month.
MET monthly report
—
Key takeaways
- MetLife (MET) closed November 2026 at $102.65, up 2.63% for the month and +29.17% over the trailing 12 months.
- Year-to-date, MET is +30.04%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +18.25% versus its 200-day moving average ($86.80), a bullish technical signal.
- Over the past three years, MET has underperformed the S&P 500 by −1.59%, with a relative strength index reading of 99.1.
- Win rate over the trailing 39 months stands at 56.4% — 22 positive months versus 17 negative months.
MetLife ended November 2026 at $102.65, posting a monthly return of +2.63%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +2.81%.
The current quarter stands at +9.02% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +18.25% versus the 200-day moving average ($86.80).
Year-to-date, MET is +30.04% against SPY +10.62%, a gap of +19.41%. The stock is currently −3.81% below its 52-week high, with maximum 3-year drawdown at −23.29%.
| Period | MET | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.77% | −0.36% | +1.13% |
| 1 Week | +4.46% | +2.59% | +1.86% |
| 1 Month | +2.63% | −0.18% | +2.81% |
| 3 Months | +5.11% | −2.37% | +7.48% |
| 6 Months | +31.47% | +0.83% | +30.64% |
| YTD | +30.04% | +10.62% | +19.41% |
| 12 Months | +29.17% | +12.25% | +16.92% |
| 3 Years | +69.78% | +71.37% | −1.59% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | +13.62% |
| #2 | Apr 2026 | +13.26% |
| #3 | Nov 2024 | +12.51% |
| #4 | Jul 2024 | +9.49% |
| #5 | Aug 2025 | +7.12% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2026 | −8.63% |
| #2 | Dec 2024 | −7.20% |
| #3 | Mar 2025 | −6.83% |
| #4 | Apr 2025 | −6.13% |
| #5 | Jul 2025 | −5.56% |
| Quarter | Return |
|---|---|
| Q3 2025 | +2.42% |
| Q4 2025 | −4.16% |
| Q1 2026 | −10.41% |
| Q2 2026 | +19.64% |
| Q3 2026 | +11.29% |
| Q4 2026 (QTD) | +9.02% |
| Year | Return |
|---|---|
| 2023 | −8.62% |
| 2024 | +23.82% |
| 2025 | −3.59% |
| 2026 | +30.04% |
| Metric | Value |
|---|---|
| 52-Week High | $106.72 (2026-11-05) |
| 52-Week Low | $67.33 (2026-03-27) |
| Current Price | $102.65 |
| 200-Day Moving Average | $86.80 |
| Price vs 200DMA | +18.25% |
| 3-Year Maximum Drawdown | −23.29% (2026-03-27) |
| Current Drawdown from 52W High | −3.81% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 99.1 |
| 3-Year Excess Return vs S&P 500 | −1.59% |
| RS Peak | 107.6 (Oct 2024) |
| RS Trough | 74.7 (Mar 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was MET's return for this report period?
MET returned +2.63% in the latest monthly window ending 2026-11-13.
Has MET outperformed SPY year to date?
YTD MET: +30.04% vs SPY: +10.62%.
What is MET's 12-month return?
+29.17% over the trailing 12 months.
Is MET above or below its 200-day moving average?
Price is +18.25% versus 200DMA ($86.80).
What is the maximum drawdown in the 3-year window?
−23.29% on 2026-03-27.